x

enGene Holdings Inc. (Nasdaq:ENGN)

Health Care/Life Sciences • Biotechnology
CIK 1980845
Company

enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.

Address
4868 Rue Levy
Suite 220
Saint-Laurent, Québec H4R 2P1
Employees
33
Stock Info
Close
$5.65
Day Range
5.42 - 5.79
52 Week Range
4.42 - 18.40
Average volume
152.4K
Short Interest
88.54K (02/14/25)
% of Float Shorted
0.40%
Market Cap
$288.02M
Revenue
N/A
Net Income
-$99.92M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.50
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Ronald H. W. Cooper
Independent Non-Executive Director
Jasper Marnix Bos
Independent Non-Executive Director
Gerry Brunk
Independent Director
Lota S. Zoth
SEC filings
DateFormEvent
20 Dec, 2024 424B5
20 Dec, 2024 8-K
19 Dec, 2024 10-K
19 Dec, 2024 8-K
21 Nov, 2024 EFFECT
21 Nov, 2024 424B3
21 Nov, 2024 424B3
21 Nov, 2024 EFFECT
19 Nov, 2024 CORRESP
19 Nov, 2024 CORRESP
18 Nov, 2024 UPLOAD
18 Nov, 2024 UPLOAD
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
13 Nov, 2024 S-3
13 Nov, 2024 S-3
12 Nov, 2024 SC 13G
1 Nov, 2024 SC 13D/A
1 Nov, 2024 4
28 Oct, 2024 424B3
25 Oct, 2024 8-K
22 Oct, 2024 4
22 Oct, 2024 4
22 Oct, 2024 3
21 Oct, 2024 8-K
21 Oct, 2024 424B3
21 Oct, 2024 SCHEDULE 1
18 Oct, 2024 SC 13D/A
18 Oct, 2024 4
1 Oct, 2024 4
26 Sep, 2024 8-K
26 Sep, 2024 424B3
10 Sep, 2024 8-K
10 Sep, 2024 424B3
10 Sep, 2024 10-Q
5 Sep, 2024 8-K
25 Jul, 2024 3
25 Jul, 2024 4
24 Jul, 2024 424B3
24 Jul, 2024 3
24 Jul, 2024 8-K
24 Jul, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
14 Jun, 2024 10-Q
14 Jun, 2024 8-K
14 Jun, 2024 424B3
29 May, 2024 4
17 May, 2024 3
17 May, 2024 3
15 May, 2024 424B3
15 May, 2024 8-K
25 Apr, 2024 424B3
22 Apr, 2024 4
18 Apr, 2024 ARS
18 Apr, 2024 DEF 14A
25 Mar, 2024 4
20 Mar, 2024 4
19 Mar, 2024 4
12 Mar, 2024 424B3
11 Mar, 2024 10-Q
11 Mar, 2024 8-K
5 Mar, 2024 424B3
5 Mar, 2024 EFFECT
4 Mar, 2024 CORRESP
27 Feb, 2024 S-8
27 Feb, 2024 S-1/A
26 Feb, 2024 CORRESP
26 Feb, 2024 SC 13G
23 Feb, 2024 SC 13G
23 Feb, 2024 SC 13G
22 Feb, 2024 SC 13G/A
21 Feb, 2024 SC 13D/A
21 Feb, 2024 4
21 Feb, 2024 4
14 Feb, 2024 SC 13G
14 Feb, 2024 8-K CEO Change
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G
2 Feb, 2024 3
29 Jan, 2024 10-K
29 Jan, 2024 8-K
11 Jan, 2024 CORRESP
28 Dec, 2023 8-K
26 Dec, 2023 UPLOAD
21 Dec, 2023 8-K
19 Dec, 2023 3
15 Dec, 2023 S-1/A
15 Dec, 2023 CORRESP
13 Dec, 2023 8-K
8 Dec, 2023 UPLOAD
4 Dec, 2023 4
4 Dec, 2023 4
29 Nov, 2023 3
29 Nov, 2023 8-K
22 Nov, 2023 S-1
13 Nov, 2023 SC 13G
13 Nov, 2023 3
13 Nov, 2023 3
13 Nov, 2023 SC 13D
13 Nov, 2023 SC 13G
9 Nov, 2023 8-K
8 Nov, 2023 SC 13D
7 Nov, 2023 SC 13G
7 Nov, 2023 3
2 Nov, 2023 4
2 Nov, 2023 4
2 Nov, 2023 4
2 Nov, 2023 4
2 Nov, 2023 4
2 Nov, 2023 4
2 Nov, 2023 4
2 Nov, 2023 3
31 Oct, 2023 3
31 Oct, 2023 CERT
31 Oct, 2023 8-A12B
31 Oct, 2023 3
31 Oct, 2023 3
31 Oct, 2023 3
31 Oct, 2023 3
31 Oct, 2023 3
31 Oct, 2023 8-K
31 Oct, 2023 3
31 Oct, 2023 3
31 Oct, 2023 3
31 Oct, 2023 3
24 Oct, 2023 425
2 Oct, 2023 424B3
29 Sep, 2023 EFFECT
29 Sep, 2023 SEC STAFF
28 Sep, 2023 CORRESP
26 Sep, 2023 S-4/A
25 Sep, 2023 CORRESP
15 Sep, 2023 425
11 Sep, 2023 UPLOAD
30 Aug, 2023 S-4/A
29 Aug, 2023 CORRESP
22 Aug, 2023 SEC STAFF
22 Aug, 2023 UPLOAD
9 Aug, 2023 CORRESP
9 Aug, 2023 S-4
12 Jul, 2023 UPLOAD
14 Jun, 2023 DRS
Last update:2025-03-06 12:06:25.669377
enGene Holdings Inc. by TradingView

Sign Up to Subscribe